Amgen
$251.009876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$251.00
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$7.54 (-2.92%) Today
-$0.06 (-0.02%) As of 1:00 AM UTC after-hours
Why Robinhood?
You can buy or sell Amgen and other stocks, options, and ETFs commission-free!
About AMGN
Amgen Inc. Common Stock, also called Amgen, is a biotechnology company, which engages in the discovery, development, manufacture and marketing of human therapeutics. Its products include the following brands: Aranesp, BLINCYTO, Corlanor, ENBREL, EPOGEN, IMLYGIC, KYPROLIS, Neulasta, NEUPOGEN, Nplate, Parsabiv, Prolia, Repatha, Sensipar, Vectibix, and XGEVA. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA. The listed name for AMGN is Amgen Inc. Common Stock.
CEO
Robert A. Bradway
Employees
23,400
Headquarters
Thousand Oaks, California
Founded
1980
Market Cap
143.28B
Price-Earnings Ratio
20.74
Dividend Yield
2.49
Average Volume
2.41M
High Today
$259.44
Low Today
$250.32
Open Price
$255.31
Volume
3.24M
52 Week High
$264.97
52 Week Low
$177.05
Collections
AMGN News
Analyst Ratings
47%
of 30 ratings
Buy
47%
Hold
50%
Sell
3%
AMGN Earnings
$0.00
$1.46
$2.91
$4.37
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Available Feb 2, After Hours